AXIOM is a Technology Growth buyout investor with deep understanding in advanced manufacturing, healthcare and clean energy (ESG) sectors. We partner with industrial investors and/or other matured industrial PE house to capture fast growing companies with China angle, providing capital, operating strategies support.
We have 20+ years of combined Industrial, M&A and Investment experience.Including 10 years of dedicated Cross-border M&A and investment between China and Europe.
We are globally educated and culturally inclusive due to education, life and work experiences in Europe and the US.
We aim to capture value in the significant growth momentum driven by strong technology upgrade demands across advanced manufacturing, healthcare and clean energy (ESG) sectors in China, as the country is expanding towards the world’s largest economy.
We work with visionary entrepreneurs to acquire talents and technologies globally (e.g., Europe) to accelerate growth in China markets.
We will, through co-investment with industrial investors and/or matured industrial PE house, actively implement specific value creation measures for relevant technology applications in China during investment period.
Clean Energy / Tech: e.g., Solar, Wind and Hydrogen generation, Bio and recycle solutions
Automotive & Manufacturing: e.g., ADAS, Autonomous Driving, Automation, Sensor, Optics, Precision tech
MedTech: e.g., Medical Devices, Diagnostic Equipment, Consumables
AXIOM, on-shore RMB denominated structure is founded with further supported by guidance funds in the “Yangtze River Delta”, as parallel fund to Cornucopia. AXIOM is better positioned to i) help portfolios execute organic value creation measures China market; ii) add “dry-powders” for China bolt-on acquisitions; iii) enable the possibility of potential IPO in greater China markets.
We founded ADDOR Cornucopia, in a new partnership ADDOR Capital, who is the 3rd largest Chinese provincial sovereign wealth asset management firm, to upscale our sector fund activity, with aim to participate more influential deals. Cornucopia is a USD denominated structure registered in Hong Kong, regulated in Cayman Island.
With major policy update, i.e., ODI in 2017, cross-border M&As became even more strategic oriented and increasingly focus on advanced manufacturing, MedTech, and clean energy topics. Deal approaches changed from pure transaction services towards sector fund partnership with industrial leaders, coving full life cycle of investments including deal sourcing, financing, portfolio management with China strategy, and refinancing.
Taking the advantages of team’s European roots and seasoned multi-cultural transaction experience, we completed several landmark Sino-European transactions M&A and sector fund investments, in which Chinese player made successful strategic transformation through the acquisitions:, e.g. Deren’s acquisition of Meta System, CCTC’s acquisition of Vermes.
Partner with IEG Investment Banking for technology cross-borer M&A in China. We were uniquely active in various cross-border investments and broadly recognized as experienced deal makers in major European markets such as Germany, Italy and France. IEG China became a major M&A power house in China relative to IEG’s other European peers.
Kratos, one of the first Chinese buy-side advisory team was funded specifically for mid-cap M&As by Chinese strategic investors, towards European deals. Kratos was active in industrial technologies, automotive electronics and consumer sectors at the beginning.
© 2024 Axiom Advisory Limited – All rights reserved